Garrison Bradford & Associates’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Garrison Bradford & Associates’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-487	Closed	-$40.4K	–	58
2025 Q2	$40.4K	Hold	487	–	–	0.04%	50
2025 Q1	$39.5K	Buy	+487	New	+$43.5K	0.04%	50
2023 Q4	–	Sell	-2,955	Closed	-$216K	–	32
2023 Q3	$216K	Hold	2,955	–	–	0.26%	28
2023 Q2	$246K	Hold	2,955	–	–	0.3%	30
2023 Q1	$225K	Hold	2,955	–	–	0.28%	34
2022 Q4	$245K	Hold	2,955	–	–	0.3%	37
2022 Q3	$234K	Sell	2,955 -1,160	-28%	-$97.8K	0.28%	40
2022 Q2	$306K	Hold	4,115	–	–	0.35%	34
2022 Q1	$370K	Sell	4,115 -100	-2%	-$9.23K	0.36%	34
2021 Q4	$472K	Sell	4,215 -590	-12%	-$71.2K	0.42%	34
2021 Q3	$604K	Hold	4,805	–	–	0.61%	27
2021 Q2	$651K	Buy	4,805 +300	+7%	+$39.4K	0.68%	27
2021 Q1	$611K	Buy	4,505 +505	+13%	+$75.6K	0.68%	28
2020 Q4	$563K	Buy	4,000 +700	+21%	+$89.7K	0.69%	29
2020 Q3	$368K	Sell	3,300 -60	-2%	-$6.73K	0.52%	30
2020 Q2	$376K	Sell	3,360 -150	-4%	-$14.8K	0.55%	28
2020 Q1	$272K	Sell	3,510 -500	-12%	-$44.3K	0.47%	31
2019 Q4	$381K	Hold	4,010	–	–	0.48%	32
2019 Q3	$306K	Buy	4,010 +60	+2%	+$4.99K	0.42%	35
2019 Q2	$346K	Hold	3,950	–	–	0.4%	42
2019 Q1	$358K	Buy	+3,950	New	+$336K	0.3%	54

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Garrison Bradford & Associates's XBI Position: Q3 2025 in Review

Garrison Bradford & Associates sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 487 shares — an estimated $40.4K sold.

Garrison Bradford & Associates first reported a position in XBI in Q1 2019 and held it in 21 quarters. The position peaked at $651K in Q2 2021. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

Garrison Bradford & Associates reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
Garrison Bradford & Associates sold 487 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $40.4K.
Garrison Bradford & Associates first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and held it in 21 quarters.
Garrison Bradford & Associates's State Street SPDR S&P Biotech ETF position peaked at $651K in Q2 2021.
656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on Garrison Bradford & Associates's 13F filing for Q3 2025, filed 4 Nov 2025.